{
  "id": 13884768,
  "title": "Freenome To Present Improved Precancerous Lesion Detection Data For CRC Blood Test",
  "url": "https://urgent.news/2026/10/12/freenome-to-present-improved-precancerous-lesion-detection-data-for",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-12T04:52:16.000Z",
  "source": {
    "name": "Nasdaq Markets",
    "slug": "nasdaq-markets",
    "url": "https://www.nasdaq.com/articles/freenome-present-improved-precancerous-lesion-detection-data-crc-blood-test"
  },
  "original_language": "en",
  "account": null,
  "summary": "(RTTNews) - On Sunday, Freenome, Inc. (FRNM) said it will present new clinical validation data for an updated version of its SimpleScreen colorectal cancer (CRC) blood-based screening test at the American College of Gastroenterology (ACG) 2026 Annual Meeting in Nashville.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}